GeneDx Holdings Corp.·4

Nov 21, 8:21 PM ET

Ryan Jason 4

4 · GeneDx Holdings Corp. · Filed Nov 21, 2024

Insider Transaction Report

Form 4
Period: 2024-11-19
Ryan Jason
Director
Transactions
  • Sale

    Class A Common Stock

    2024-11-20$70.50/sh4,272$301,1850 total(indirect: By Jason Ryan u/a dtd 11/25/2018)
  • Gift

    Class A Common Stock

    2024-11-19141,35647,000 total(indirect: By Trust)
  • Sale

    Class A Common Stock

    2024-11-20$69.84/sh1,857$129,6894,272 total(indirect: By Trust)
  • Sale

    Class A Common Stock

    2024-11-19$70.86/sh5,952$421,78441,048 total(indirect: By Trust)
  • Sale

    Class A Common Stock

    2024-11-19$71.35/sh24,784$1,768,42016,264 total(indirect: By Trust)
  • Sale

    Class A Common Stock

    2024-11-19$72.26/sh774$55,92715,490 total(indirect: By Trust)
  • Sale

    Class A Common Stock

    2024-11-20$68.36/sh9,361$639,8766,129 total(indirect: By Trust)
Holdings
  • Class A Common Stock

    (indirect: By Jason Ryan 2024 GRAT)
    141,356
  • Class A Common Stock

    130
Footnotes (7)
  • [F1]On November 19, 2024, the reporting person transferred 141,356 shares of GeneDx Holdings Corp. Class A common stock from the reporting person's indirect holdings to the Jason Ryan 2024 GRAT (the "GRAT") for no consideration. The reporting person is the trustee of the GRAT, and the reporting person is the sole annuitant of the grantor retained annuity trust. The reporting person remains the beneficial owner of the securities held by the grantor retained annuity trust.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.026 to $71.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.04 to $72.0302 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.12 to $72.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.01 to $68.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.22 to $70.21 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F7]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.22 to $70.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    form4-11222024_011124.xmlPrimary